UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer

Molecular cancer, 2017-11, Vol.16 (1), p.169-169, Article 169

2017

Volltextzugriff (PDF)

LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma

Journal of hematology and oncology, 2022-05, Vol.15 (1), p.52-52, Article 52

2022

Volltextzugriff (PDF)

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study

BMC cancer, 2022-06, Vol.22 (1), p.649-649, Article 649

2022

Volltextzugriff (PDF)

Melittin inhibits tumor growth and decreases resistance to gemcitabine by downregulating cholesterol pathway gene CLU in pancreatic ductal adenocarcinoma

Cancer letters, 2017-07, Vol.399, p.1-9

2017

Volltextzugriff (PDF)

A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer

Frontiers in oncology, 2021-03, Vol.11, p.634881

2021

Volltextzugriff (PDF)

Targeting KRASG12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors

Frontiers in immunology, 2023-05, Vol.14, p.1161538-1161538

2023

Volltextzugriff (PDF)

Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: results from a longitudinal cohort and mendelian randomization study

The Lancet regional health. Western Pacific, 2023-01, Vol.30, p.100596-100596, Article 100596

2023

Volltextzugriff (PDF)

Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort

EBioMedicine, 2021-12, Vol.74, p.103716, Article 103716

2021

Volltextzugriff (PDF)

BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1

Advanced science, 2024-02, Vol.11 (7), p.e2306298-n/a

2024

Volltextzugriff (PDF)

SY5-2. Specific human leukocyte antigen supertypes against prognosis in resected pancreatic adenocarcinoma

Journal of the Japan Pancreas Society, 2022, Vol.37 (3), p.A198-A198

Chenlei Wen

2022

Volltextzugriff (PDF)

CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches

Cell reports. Medicine, 2024-09, Vol.5 (9), p.101692, Article 101692

2024

Volltextzugriff (PDF)

Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma

Cancer medicine (Malden, MA), 2020-10, Vol.9 (20), p.7626-7636

2020

Volltextzugriff (PDF)

MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells

Biochemical and biophysical research communications, 2017-02, Vol.483 (2), p.816-822

2017

Volltextzugriff (PDF)

Molecular subtypes of pancreatic adenocarcinoma stratified based on copy number variation profile

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16232-e16232

2021

Volltextzugriff (PDF)

Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment

Gut, 2023-05, Vol.72 (5), p.958-971

2023

Volltextzugriff (PDF)

Perioperative fuzuloparib plus mFOLFIRINOX for resectable pancreatic adenocarcinoma: A phase 1 study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4163-4163

2024

Volltextzugriff (PDF)

Melittin-induced long non-coding RNA NONHSAT105177 inhibits proliferation and migration of pancreatic ductal adenocarcinoma

Cell death & disease, 2018-09, Vol.9 (10), p.940-11, Article 940

2018

Volltextzugriff (PDF)

Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes

Cancer letters, 2024-09, Vol.599, p.217134, Article 217134

2024

Volltextzugriff (PDF)

Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors

Cell research, 2024-09, Vol.34 (9), p.661-664

2024

Volltextzugriff (PDF)

Modified protocol for enhanced recovery after surgery is beneficial for Chinese cancer patients undergoing pancreaticoduodenectomy

Oncotarget, 2017-07, Vol.8 (29), p.47841-47848

2017

Volltextzugriff (PDF)

Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling

Theranostics, 2023-01, Vol.13 (10), p.3290-3309

2023

Volltextzugriff (PDF)

mir-329 restricts tumor growth by targeting grb2 in pancreatic cancer

Oncotarget, 2016-04, Vol.7 (16), p.21441-21453

2016

Volltextzugriff (PDF)

Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism

Advanced science, 2024-09, p.e2308990

2024

Volltextzugriff (PDF)

Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study

International journal of surgery (London, England), 2023-07, Vol.109 (7), p.1941-1952

2023

Volltextzugriff (PDF)

SY7-5. Kras-mutated acinar-metaplastic cells in panIN present invasive properties related to early metastasis in PDAC

Journal of the Japan Pancreas Society, 2022, Vol.37 (3), p.A205-A206

2022

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(95)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(24)
Humans
(16)
Pancreatic Cancer
(14)
Oncology
(10)
Pancreatic Neoplasms - Genetics
(9)
Male
(7)
Physical Sciences
(7)
Technology
(7)
Adenocarcinoma
(6)
Cell Biology
(6)
Female
(6)
Medical Prognosis
(6)
Pancreas
(6)
Pancreatic Neoplasms - Pathology
(6)
Animals
(5)
Carcinoma, Pancreatic Ductal - Genetics
(5)
Carcinoma, Pancreatic Ductal - Pathology
(5)
Cell Line, Tumor
(5)
Middle Aged
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer

LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study

Melittin inhibits tumor growth and decreases resistance to gemcitabine by downregulating cholesterol pathway gene CLU in pancreatic ductal adenocarcinoma

A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer

Targeting KRASG12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors

Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: results from a longitudinal cohort and mendelian randomization study

Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort

BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1

SY5-2. Specific human leukocyte antigen supertypes against prognosis in resected pancreatic adenocarcinoma

CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches

Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma

MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells

Molecular subtypes of pancreatic adenocarcinoma stratified based on copy number variation profile

Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment

Perioperative fuzuloparib plus mFOLFIRINOX for resectable pancreatic adenocarcinoma: A phase 1 study

Melittin-induced long non-coding RNA NONHSAT105177 inhibits proliferation and migration of pancreatic ductal adenocarcinoma

Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes

Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors

Modified protocol for enhanced recovery after surgery is beneficial for Chinese cancer patients undergoing pancreaticoduodenectomy

Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling

mir-329 restricts tumor growth by targeting grb2 in pancreatic cancer

Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism

Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study

SY7-5. Kras-mutated acinar-metaplastic cells in panIN present invasive properties related to early metastasis in PDAC

Suchergebnisse filtern